Regulatory update (April 2026): This peptide was removed from the FDA's Category 2 'Do Not Compound' list effective April 22, 2026
GLP-1RAs work by reducing the appetite and feelings of hunger, slowing the release of food from the stomach, and increasing feelings of fullness after eating
PlexusDx pricing for compounded tirzepatide injections ranges $289/mo month-to-month, or from $249/mo on the 6-month plan depending on dose strength and formulation, while oral tirzepatide extends $349/mo month-to-month, or from $279/mo on the 6-month plan
Monitoring Response Patients or research participants typically notice: Appetite suppression within the first 12 weeks Early satiety and slower gastric emptying by weeks 34 Weight loss trends becoming evident by week 8 Continued improvements in glucose metabolism when paired with semaglutide or tirzepatide Side Effects and Considerations Common side effects include: Nausea Mild gastrointestinal discomfort Constipation Injection site reactions These effects are generally transient and dose-dependent, which is why titration is important
By activating the GLP-1 receptors in your body, these medications help you feel fuller for longer and reduce your overall calorie intake
We want to help you decide which one you need